![](/rp/kFAqShRrnkQMbH6NYLBYoJ3lq9s.png)
Osteoporosis treatment: Medications can help - Mayo Clinic
2024年8月28日 · Romosozumab is given as a monthly injection at your healthcare professional's office. It is a new drug and less is known about long-term side effects. It is not given to people who have recently had a stroke or heart attack.
Osteoporosis - Diagnosis and treatment - Mayo Clinic
2024年2月24日 · If you have severe osteoporosis or if the more common treatments for osteoporosis don't work well enough, your doctor might suggest trying: Teriparatide (Bonsity, Forteo). This powerful drug is similar to parathyroid hormone and stimulates new bone growth. It's given by daily injection under the skin for up to two years.
Denosumab (subcutaneous route) - Mayo Clinic
It is also used to treat osteoporosis in patients using steroid medicines for at least 6 months. Denosumab injection is also used to treat bone loss in men with prostate cancer and women with breast cancer who are at high risk for fracture receiving treatment for their cancer that has not spread throughout the body.
Zoledronic acid (intravenous route) - Mayo Clinic
2025年2月1日 · Zoledronic acid injection is also used to treat Paget's disease of the bone in men and women. It is also used in men with osteoporosis and in women with osteoporosis who have gone through menopause. This medicine is used to reduce the risk of having more fractures in patients who have had a recent hip fracture.
Teriparatide (subcutaneous route) - Mayo Clinic
Teriparatide injection is also used to treat osteoporosis caused by steroid (glucocorticoid) medicine in men and women who are at high risk for bone fracture or cannot use other osteoporosis treatments. Teriparatide is a synthetic form of …
Osteoporosis - Symptoms and causes - Mayo Clinic
2024年2月24日 · Osteoporosis causes bones to become weak and brittle — so brittle that a fall or even mild stresses such as bending over or coughing can cause a break. Osteoporosis-related breaks most commonly occur in the hip, wrist or spine. Bone is living tissue that is constantly being broken down and replaced.
Osteoporosis in COVID-19 - Mayo Clinic
2022年4月15日 · Dr. Clarke explains: "Delaying the administration of certain osteoporosis drugs can have ominous consequences, such as loss of bone mass, increase in bone turnover and increase in fracture risk. Because there is paucity of data to provide evidence-based clinical recommendations, we formed an expert consensus on best practices.
Denosumab-bbdz (subcutaneous route) - Mayo Clinic
It is also used to treat osteoporosis in patients using steroid medicines for at least 6 months. Denosumab-bbdz injection is also used to treat bone loss in males with nonmetastatic (has not spread) prostate cancer and females with nonmetastatic breast cancer who are at high risk for fracture after receiving cancer treatment.
Romosozumab-aqqg (subcutaneous route) - Mayo Clinic
Romosozumab-aqqg injection is used to treat osteoporosis (thinning and weakening of the bones) in postmenopausal women who are at high risk of fracture (history of osteoporotic fracture) or have used another osteoporosis medicine that did not work well. This medicine to be given only by or under the direct supervision of your doctor.
Abaloparatide (subcutaneous route) - Mayo Clinic
For injection dosage form (prefilled pen): For osteoporosis in postmenopausal women: Adults—80 micrograms (mcg) injected under the skin once a day. Children—Use and dose must be determined by your doctor.